POSC340 Health-Related Quality of Life Among Refractory/Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with KTE-X19: Phase 2 Results from Zuma-3 Trial
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1165
https://www.valueinhealthjournal.com/article/S1098-3015(21)02960-0/fulltext
Title :
POSC340 Health-Related Quality of Life Among Refractory/Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with KTE-X19: Phase 2 Results from Zuma-3 Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02960-0&doi=10.1016/j.jval.2021.11.1165
First page :
Section Title :
Open access? :
No
Section Order :
10701